DOI: 10.5281/zenodo.8392256
SOFTWARE: gromacs
TRJ:
- - PC_PE_CL_570Run.xtc
TPR:
- - PC_PE_CL_570Run.gro
PREEQTIME: 0
TIMELEFTOUT: 120
TEMPERATURE: 310
COMPOSITION:
  TOCL:
    NAME: TOCL2
    MAPPING: mappingTOCLcharmm.yaml
    COUNT:
    - 15
    - 15
  POPC:
    NAME: POPC
    MAPPING: mappingPOPCcharmm.yaml
    COUNT:
    - 30
    - 30
  POPE:
    NAME: POPE
    MAPPING: mappingPOPEcharmm.yaml
    COUNT:
    - 15
    - 15
  SOL:
    NAME: TIP3
    MAPPING: mappingTIP3PCHARMMgui.yaml
    COUNT: 9000
  SOD:
    NAME: SOD
    MAPPING: mappingSOD.yaml
    COUNT: 60
DIR_WRK: /home/sosamuli/temp/DataBank/
PUBLICATION: Castillo et al, 2022, Mol. Pharmaceutics. 19:1839-1852 (https://doi.org/10.1021/acs.molpharmaceut.1c00926)
AUTHORS_CONTACT: Milka Doktorova
SYSTEM: POPC/POPE/TOCL mixture
SOFTWARE_VERSION: null
FF: Charmm36
FF_SOURCE: null
FF_DATE: null
TOP: null
TRAJECTORY_SIZE: 4872398524
TRJLENGTH: 570020.0
NUMBER_OF_ATOMS: 46290
DATEOFRUNNING: 05/10/2023
TYPEOFSYSTEM: lipid bilayer
ID: 787
EXPERIMENT:
  ORDERPARAMETER:
    TOCL: {}
    POPC: {}
    POPE: {}
  FORMFACTOR: {}
